Table 6 Pharmacotherapies during admission and discharge
Bleeding | ||||
|---|---|---|---|---|
Drugs used | Overall, N = 2021 | No, N = 1881 | Yes, N = 141 | p value2 |
Aspirin, n (%) | 202 (100.0) | 188 (100.0) | 14 (100.0) | |
Gp 2b/3a inhibitors, n (%) | 62 (30.7) | 56 (29.8) | 6 (42.9) | 0.37 |
GP 2b/3a inhibitors, n (%) | 0.61 | |||
In Cath lab | 47 (77.0) | 43 (78.2) | 4 (66.7) | |
Thrombolysis, n (%) | 18 (8.9) | 18 (9.6) | 0 (0.0) | 0.62 |
Other antiplatelet, n (%) | 0.57 | |||
Clopidogrel | 119 (58.9) | 111 (59.0) | 8 (57.1) | |
Prasugrel | 16 (7.9) | 16 (8.5) | 0 (0.0) | |
Ticagrelor | 67(33.2) | 61(32.4) | 6(42.9) | |
Beta blocker, n (%) | 156(77.2) | 145(77.1) | 11 (78.9) | > 0.99 |
ACE inhibitors, n (%) | 93 (46.0) | 89 (47.3) | 4 (28.6) | 0.32 |
Statin, n (%) | 178 (89.4) | 164 (88.6) | 14 (100.0) | 0.37 |
PPI, n (%) | 132 (71.7) | 121 (70.3) | 11 (91.7) | 0.18 |